CEO Christopher Viehbacher told investors at TD Cowen’s 46th Annual Healthcare Conference that the company is focused on ...
The science behind rare disease treatments is advancing at an unprecedented pace. Biogen is sharpening its long-term strategy ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM ESTCompany ParticipantsChristopher Viehbacher - President, CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results